Douglas A Fellman

For more than 25 years, Douglas Fellman has represented public and private companies, boards of directors, board committees, and individual officers and directors regarding government and internal investigations, corporate governance matters, and "sticky issues" that occasionally arise at even the best of companies.

While these matters can be among the most consequential and sensitive for his clients, Doug is known for his sound judgment and strategic thinking, business acumen and practicality, and for the sense of calm and discretion that he brings to the representations he leads.

Doug has represented clients in connection with civil, criminal, and administrative investigations and other proceedings involving the U.S. Department of Justice, Securities and Exchange Commission, and other federal and state departments and agencies, often involving cross-border and other multi-jurisdiction or parallel proceedings.

As Doug works with and defends clients, he often advises company senior management and boards of directors on matters of corporate governance, officer and director fiduciary duty, and interactions with outside auditors and other constituencies, including in the context of current or possible future strategic transactions.

Doug regularly represents clients in enforcement matters involving whistleblower complaints and other alleged compliance exceptions, financial restatements, accounting irregularities, insider trading, and the Foreign Corrupt Practices Act (FCPA). He also has comprehensive knowledge of the Food Drug and Cosmetic Act (with extensive experience representing clients in the food industry in criminal and other enforcement investigations), as well as international trade laws and regulations involving the Commerce, Treasury, and State Departments, government contacts and related suspension and debarment issues, and many other regulatory frameworks. In addition, Doug has successfully represented public companies in matters involving the NYSE, NASDAQ, FINRA, the CBOE, and other regulatory bodies.